Abstract
Tissue plasminogen activator (tPA) is able to dissolve any fibrin material that forms in the anterior chamber or vitreous humor. This property has been reported by various experimental studies performed in rabbits.
The authors demonstrate the tPA eye drops administered to patients with postoperative hyphema, which did not respond to traditional therapy, gave rapid clearance of the clot.
Following its topical administration for the first time in patients, the harmless nature of the drug is emphasized as well as its efficacy. This study indicates the promising features of this drug which deserve further investigation.
Similar content being viewed by others
References
Crabbe SI, Cloninger CC. Tissue plasminogen activator: a new thrombolytic agent. Clin Pharm 1987; 6: 373–86.
Howard GR, Vukich J, Fiscella RG, Farber MD, Goldberg MF. Intraocular tissue plasminogen activator in a rabbit model of traumatic hyphema. Arch Ophthalmol 1991; 109: 272–4.
Jaffe JG, Hilel L, Han DP, Williams GA, Abrams GW. Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator. Am J Ophthalmol 1989; 108: 170–5.
Johnson MW, Olsen KR, Hernandez E, Irvine WD, Johnson RN. Retinal toxicity of recombinant tissue plasminogen activator in rabbit. Arch Ophthalmol 1990; 108:259–63.
Johnson RN, Olsen K, Hernandez E. Tissue plasminogen activator treatment of postoperative intraocular fibrin. Ophthalmology 1988; 95: 592–5.
Lambrou FH, Snyder RW, Williams GA, Lewandowski M. Treatment of experimental intravitreal fibrin with tissue plasminogen fibrin. Am Ophthalmol 1987; 104: 619–23.
Leet DM. Treatment of total hyphemas with urokinase. Am J Ophthalmol 1977; 84:79–84.
Liebman SD, Pollen A, Podos SM. Treatment of experimental total hyphema with intraocular fibrinolytic agents. Arch Ophthalmol 1962; 68: 102–8.
Lim JI, Fiscella R, Tessler H, Gagliano DA, Alepuz VC, Mohler MA. Intraocular penetration of topical tissue plasminogen activator. Arch Ophthalmol 1991; 109:714–7.
O'Rourke JF. An evaluation of intraocular streptokinase. Am J Ophthalmol 1955; 39: 119–36.
Snyder RW, Lambrou FH, Williams GA. Intraocular fibrinolysis with recombinant human tissue plasminogen activator. Arch Ophthalmol 1987; 105: 1277–80.
Williams GA, Lambrou FH, Jaffe GA, Snyder RW, Green GDJ, Devenyi RG, Abrams GW. Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator. Arch Ophthalmol 1988; 106:1055–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cellini, M., Baldi, A. & Possati, G.L. Topical treatment of postvitrectomy fibrin formation with tissue plasminogen activator. Int Ophthalmol 18, 351–353 (1994). https://doi.org/10.1007/BF00930313
Issue Date:
DOI: https://doi.org/10.1007/BF00930313